"It Will Lead to Immorality": Key Points of the Controversy Over Abortion Pills / SBS News

The controversy surrounding the abortion pill "Mifegymiso" is growing.
This is because discussions have gained momentum as the government pushes for the official introduction of Mifegymiso in South Korea.

As many countries already utilize abortion pills as pharmaceuticals,
there are loud calls to safely manage them within the official healthcare system domestically as well.
On the other hand, concerns regarding the safety of the drug and its ethical ripple effects remain deeply divided.

While the government is pushing to grant product approval and establish a system with the goal of introducing it in the first quarter of next year,
what further discussions need to take place moving forward?

SBS News has summarized the controversies surrounding the introduction of Mifegymiso.

(Producer: Kim Hye-ji, Editing: Lee Ji-soo, Narration: Han Ji-ho, Intern: Nam Min-jin, Direction: Kwon Na-young)
※ Please note: This article was translated by AI and may contain errors.